메뉴 건너뛰기




Volumn 5, Issue 5, 2016, Pages

Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms

Author keywords

Atherosclerosis; Atrial fibrillation; Myocardial infarction

Indexed keywords

2MACE SCORE; ANKLE BRACHIAL INDEX; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR RISK; CHADS2 SCORE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; FLOW-MEDIATED DILATION TEST; GEOGRAPHIC DISTRIBUTION; HASBLED SCORE; HEART FAILURE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; MEDICAL HISTORY; METABOLIC SYNDROME X; PREDICTIVE VALUE; PRIORITY JOURNAL; RESOURCE ALLOCATION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SCORING SYSTEM; SYSTEMATIC REVIEW; THROMBOCYTE ACTIVATION; VASCULAR DISEASE; HEART MUSCLE REVASCULARIZATION; INCIDENCE; UTILIZATION;

EID: 85020498013     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.116.003347     Document Type: Article
Times cited : (165)

References (78)
  • 7
    • 80054936056 scopus 로고    scopus 로고
    • One-year cardiovascular event rates in Japanese outpatients with myocardial infarction, stroke, and atrial fibrillation. Results from the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE)
    • Goto S, Ikeda Y, Shimada K, Uchiyama S, Origasa H, Kobayashi H; Investigators JT. One-year cardiovascular event rates in Japanese outpatients with myocardial infarction, stroke, and atrial fibrillation. Results from the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE). Circ J. 2011;75:2598-2604.
    • (2011) Circ J , vol.75 , pp. 2598-2604
    • Goto, S.1    Ikeda, Y.2    Shimada, K.3    Uchiyama, S.4    Origasa, H.5    Kobayashi, H.6
  • 8
    • 84869501537 scopus 로고    scopus 로고
    • Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: findings from the ADHERE registry linked to Medicare claims
    • Hess PL, Greiner MA, Fonarow GC, Klaskala W, Mills RM, Setoguchi S, Al-Khatib SM, Hernandez AF, Curtis LH. Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: findings from the ADHERE registry linked to Medicare claims. Clin Cardiol. 2012;35:649-657.
    • (2012) Clin Cardiol , vol.35 , pp. 649-657
    • Hess, P.L.1    Greiner, M.A.2    Fonarow, G.C.3    Klaskala, W.4    Mills, R.M.5    Setoguchi, S.6    Al-Khatib, S.M.7    Hernandez, A.F.8    Curtis, L.H.9
  • 10
    • 84909974321 scopus 로고    scopus 로고
    • Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: a nationwide cohort study of 9519 patients
    • Andersson T, Magnuson A, Bryngelsson IL, Frobert O, Henriksson KM, Edvardsson N, Poci D. Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: a nationwide cohort study of 9519 patients. Int J Cardiol. 2014;177:91-99.
    • (2014) Int J Cardiol , vol.177 , pp. 91-99
    • Andersson, T.1    Magnuson, A.2    Bryngelsson, I.L.3    Frobert, O.4    Henriksson, K.M.5    Edvardsson, N.6    Poci, D.7
  • 16
    • 84905189018 scopus 로고    scopus 로고
    • Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study
    • Martinez C, Katholing A, Freedman SB. Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study. Thromb Haemost. 2014;112:276-286.
    • (2014) Thromb Haemost , vol.112 , pp. 276-286
    • Martinez, C.1    Katholing, A.2    Freedman, S.B.3
  • 17
    • 84897883176 scopus 로고    scopus 로고
    • Myocardial ischemic events in 'real world' patients with atrial fibrillation treated with dabigatran or warfarin
    • Larsen TB, Rasmussen LH, Gorst-Rasmussen A, Skjoth F, Rosenzweig M, Lane DA, Lip GY. Myocardial ischemic events in 'real world' patients with atrial fibrillation treated with dabigatran or warfarin. Am J Med. 2014;127:329-336.e324.
    • (2014) Am J Med , vol.127 , pp. 329-336
    • Larsen, T.B.1    Rasmussen, L.H.2    Gorst-Rasmussen, A.3    Skjoth, F.4    Rosenzweig, M.5    Lane, D.A.6    Lip, G.Y.7
  • 19
    • 84919860496 scopus 로고    scopus 로고
    • Atrial fibrillation and incident myocardial infarction in the elderly
    • O'Neal WT, Sangal K, Zhang ZM, Soliman EZ. Atrial fibrillation and incident myocardial infarction in the elderly. Clin Cardiol. 2014;37:750-755.
    • (2014) Clin Cardiol , vol.37 , pp. 750-755
    • O'Neal, W.T.1    Sangal, K.2    Zhang, Z.M.3    Soliman, E.Z.4
  • 22
    • 84966687204 scopus 로고    scopus 로고
    • XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation
    • Camm AJ, Amarenco P, Haas S, Hess S, Kirchhof P, Kuhls S, van Eickels M, Turpie AG; Investigators X: XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation. Eur Heart J. 2015;37:1145-1153.
    • (2015) Eur Heart J , vol.37 , pp. 1145-1153
    • Camm, A.J.1    Amarenco, P.2    Haas, S.3    Hess, S.4    Kirchhof, P.5    Kuhls, S.6    van Eickels, M.7    Turpie, A.G.8
  • 23
    • 84935521079 scopus 로고    scopus 로고
    • Atrial fibrillation and risk of ST-segment-elevation versus non-ST-segment-elevation myocardial infarction: the Atherosclerosis Risk in Communities (ARIC) Study
    • Soliman EZ, Lopez F, O'Neal WT, Chen LY, Bengtson L, Zhang ZM, Loehr L, Cushman M, Alonso A. Atrial fibrillation and risk of ST-segment-elevation versus non-ST-segment-elevation myocardial infarction: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2015;131:1843-1850.
    • (2015) Circulation , vol.131 , pp. 1843-1850
    • Soliman, E.Z.1    Lopez, F.2    O'Neal, W.T.3    Chen, L.Y.4    Bengtson, L.5    Zhang, Z.M.6    Loehr, L.7    Cushman, M.8    Alonso, A.9
  • 27
    • 0345414673 scopus 로고    scopus 로고
    • Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial
    • Olsson SB; Executive Steering Committee of the SIIII. Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial. Lancet. 2003;362:1691-1698.
    • (2003) Lancet , vol.362 , pp. 1691-1698
    • Olsson, S.B.1
  • 28
    • 33744945247 scopus 로고    scopus 로고
    • Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE W): a randomised controlled trial
    • Investigators AWGotA, Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE W): a randomised controlled trial. Lancet. 2006;367:1903-1912.
    • (2006) Lancet , vol.367 , pp. 1903-1912
    • Connolly, S.1    Pogue, J.2    Hart, R.3    Pfeffer, M.4    Hohnloser, S.5    Chrolavicius, S.6    Pfeffer, M.7    Hohnloser, S.8    Yusuf, S.9
  • 29
    • 42349110494 scopus 로고    scopus 로고
    • Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trial
    • Hart RG, Bhatt DL, Hacke W, Fox KA, Hankey GJ, Berger PB, Hu T, Topol EJ; Investigators C. Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trial. Cerebrovasc Dis. 2008;25:344-347.
    • (2008) Cerebrovasc Dis , vol.25 , pp. 344-347
    • Hart, R.G.1    Bhatt, D.L.2    Hacke, W.3    Fox, K.A.4    Hankey, G.J.5    Berger, P.B.6    Hu, T.7    Topol, E.J.8
  • 38
    • 84891353605 scopus 로고    scopus 로고
    • Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC guidelines on atrial fibrillation: primary results of the Prevention of Thromboemolic Events-European Registry in Atrial Fibrillation (PREFER in AF)
    • Kirchhof P, Ammentorp B, Darius H, De Caterina R, Le Heuzey JY, Schilling RJ, Schmitt J, Zamorano JL. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC guidelines on atrial fibrillation: primary results of the Prevention of Thromboemolic Events-European Registry in Atrial Fibrillation (PREFER in AF). Europace. 2014;16:6-14.
    • (2014) Europace , vol.16 , pp. 6-14
    • Kirchhof, P.1    Ammentorp, B.2    Darius, H.3    De Caterina, R.4    Le Heuzey, J.Y.5    Schilling, R.J.6    Schmitt, J.7    Zamorano, J.L.8
  • 40
    • 84941952876 scopus 로고    scopus 로고
    • Inflammation and hemostasis in atrial fibrillation and coronary heart disease: the reasons for geographic and racial differences in stroke study
    • O'Neal WT, Soliman EZ, Howard G, Howard VJ, Safford MM, Cushman M, Zakai NA. Inflammation and hemostasis in atrial fibrillation and coronary heart disease: the reasons for geographic and racial differences in stroke study. Atherosclerosis. 2015;243:192-197.
    • (2015) Atherosclerosis , vol.243 , pp. 192-197
    • O'Neal, W.T.1    Soliman, E.Z.2    Howard, G.3    Howard, V.J.4    Safford, M.M.5    Cushman, M.6    Zakai, N.A.7
  • 41
    • 0030754003 scopus 로고    scopus 로고
    • Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease
    • Davi G, Gresele P, Violi F, Basili S, Catalano M, Giammarresi C, Volpato R, Nenci GG, Ciabattoni G, Patrono C. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. Circulation. 1997;96:69-75.
    • (1997) Circulation , vol.96 , pp. 69-75
    • Davi, G.1    Gresele, P.2    Violi, F.3    Basili, S.4    Catalano, M.5    Giammarresi, C.6    Volpato, R.7    Nenci, G.G.8    Ciabattoni, G.9    Patrono, C.10
  • 42
    • 0022764019 scopus 로고
    • 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation
    • Catella F, Healy D, Lawson JA, FitzGerald GA. 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. Proc Natl Acad Sci USA. 1986;83:5861-5865.
    • (1986) Proc Natl Acad Sci USA , vol.83 , pp. 5861-5865
    • Catella, F.1    Healy, D.2    Lawson, J.A.3    FitzGerald, G.A.4
  • 43
    • 0037065502 scopus 로고    scopus 로고
    • Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
    • Antithrombotic Trialists C. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
    • (2002) BMJ , vol.324 , pp. 71-86
  • 44
    • 41949108677 scopus 로고    scopus 로고
    • Prognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillation
    • Duygu H, Barisik V, Kurt H, Turk U, Ercan E, Kose S. Prognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillation. Europace. 2008;10:210-214.
    • (2008) Europace , vol.10 , pp. 210-214
    • Duygu, H.1    Barisik, V.2    Kurt, H.3    Turk, U.4    Ercan, E.5    Kose, S.6
  • 47
    • 0041922325 scopus 로고    scopus 로고
    • The isoprostanes: unique products of arachidonic acid oxidation-a review
    • Fam SS, Morrow JD. The isoprostanes: unique products of arachidonic acid oxidation-a review. Curr Med Chem. 2003;10:1723-1740.
    • (2003) Curr Med Chem , vol.10 , pp. 1723-1740
    • Fam, S.S.1    Morrow, J.D.2
  • 48
    • 84901008746 scopus 로고    scopus 로고
    • Supply/demand type 2 myocardial infarction: should we be paying more attention?
    • Sandoval Y, Smith SW, Thordsen SE, Apple FS. Supply/demand type 2 myocardial infarction: should we be paying more attention? J Am Coll Cardiol. 2014;63:2079-2087.
    • (2014) J Am Coll Cardiol , vol.63 , pp. 2079-2087
    • Sandoval, Y.1    Smith, S.W.2    Thordsen, S.E.3    Apple, F.S.4
  • 49
    • 84938631468 scopus 로고    scopus 로고
    • Embolic myocardial infarction as a consequence of atrial fibrillation: a prevailing disease of the future
    • Kolodgie FD, Virmani R, Finn AV, Romero ME. Embolic myocardial infarction as a consequence of atrial fibrillation: a prevailing disease of the future. Circulation. 2015;132:223-226.
    • (2015) Circulation , vol.132 , pp. 223-226
    • Kolodgie, F.D.1    Virmani, R.2    Finn, A.V.3    Romero, M.E.4
  • 51
    • 0037034968 scopus 로고    scopus 로고
    • Noninvasive surrogate markers of atherosclerosis
    • discussion 43C-44C.
    • Feinstein SB, Voci P, Pizzuto F. Noninvasive surrogate markers of atherosclerosis. Am J Cardiol. 2002;89:31C-43C; discussion 43C-44C.
    • (2002) Am J Cardiol , vol.89 , pp. 31C-43C
    • Feinstein, S.B.1    Voci, P.2    Pizzuto, F.3
  • 52
    • 84920641606 scopus 로고    scopus 로고
    • Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients
    • Perri L, Pastori D, Pignatelli P, Violi F, Loffredo L. Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients. Int J Cardiol. 2015;179:139-143.
    • (2015) Int J Cardiol , vol.179 , pp. 139-143
    • Perri, L.1    Pastori, D.2    Pignatelli, P.3    Violi, F.4    Loffredo, L.5
  • 55
    • 77649198148 scopus 로고    scopus 로고
    • Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial
    • Fowkes FG, Price JF, Stewart MC, Butcher I, Leng GC, Pell AC, Sandercock PA, Fox KA, Lowe GD, Murray GD; Aspirin for Asymptomatic Atherosclerosis T. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA. 2010;303:841-848.
    • (2010) JAMA , vol.303 , pp. 841-848
    • Fowkes, F.G.1    Price, J.F.2    Stewart, M.C.3    Butcher, I.4    Leng, G.C.5    Pell, A.C.6    Sandercock, P.A.7    Fox, K.A.8    Lowe, G.D.9    Murray, G.D.10
  • 56
    • 84859040554 scopus 로고    scopus 로고
    • Comparison of ankle-brachial index in patients with and without atrial fibrillation
    • Masanauskiene E, Naudziunas A. Comparison of ankle-brachial index in patients with and without atrial fibrillation. Medicina. 2011;47:641-645.
    • (2011) Medicina , vol.47 , pp. 641-645
    • Masanauskiene, E.1    Naudziunas, A.2
  • 57
    • 84930212512 scopus 로고    scopus 로고
    • Relationship between low ankle-brachial index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study
    • Violi F, Pastori D, Perticone F, Hiatt WR, Sciacqua A, Basili S, Proietti M, Corazza GR, Lip GY, Pignatelli P; Group AS. Relationship between low ankle-brachial index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study. BMJ Open. 2015;5:e008026.
    • (2015) BMJ Open , vol.5
    • Violi, F.1    Pastori, D.2    Perticone, F.3    Hiatt, W.R.4    Sciacqua, A.5    Basili, S.6    Proietti, M.7    Corazza, G.R.8    Lip, G.Y.9    Pignatelli, P.10
  • 60
    • 33947393160 scopus 로고    scopus 로고
    • Comparative predictive and diagnostic value of flow-mediated vasodilation in the brachial artery and intima media thickness of the carotid artery for assessment of coronary artery disease severity
    • Matsushima Y, Takase B, Uehata A, Kawano H, Yano K, Ohsuzu F, Ishihara M, Kurita A. Comparative predictive and diagnostic value of flow-mediated vasodilation in the brachial artery and intima media thickness of the carotid artery for assessment of coronary artery disease severity. Int J Cardiol. 2007;117:165-172.
    • (2007) Int J Cardiol , vol.117 , pp. 165-172
    • Matsushima, Y.1    Takase, B.2    Uehata, A.3    Kawano, H.4    Yano, K.5    Ohsuzu, F.6    Ishihara, M.7    Kurita, A.8
  • 61
    • 77957933610 scopus 로고    scopus 로고
    • Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis
    • Inaba Y, Chen JA, Bergmann SR. Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis. Int J Cardiovasc Imaging. 2010;26:631-640.
    • (2010) Int J Cardiovasc Imaging , vol.26 , pp. 631-640
    • Inaba, Y.1    Chen, J.A.2    Bergmann, S.R.3
  • 62
    • 84920641606 scopus 로고    scopus 로고
    • Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients
    • Perri L, Pastori D, Pignatelli P, Violi F, Loffredo L. Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients. Int J Cardiol. 2014;179C:139-143.
    • (2014) Int J Cardiol , vol.179C , pp. 139-143
    • Perri, L.1    Pastori, D.2    Pignatelli, P.3    Violi, F.4    Loffredo, L.5
  • 64
    • 0037116641 scopus 로고    scopus 로고
    • Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey
    • Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359.
    • (2002) JAMA , vol.287 , pp. 356-359
    • Ford, E.S.1    Giles, W.H.2    Dietz, W.H.3
  • 66
    • 40549117855 scopus 로고    scopus 로고
    • Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study
    • Watanabe H, Tanabe N, Watanabe T, Darbar D, Roden DM, Sasaki S, Aizawa Y. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation. 2008;117:1255-1260.
    • (2008) Circulation , vol.117 , pp. 1255-1260
    • Watanabe, H.1    Tanabe, N.2    Watanabe, T.3    Darbar, D.4    Roden, D.M.5    Sasaki, S.6    Aizawa, Y.7
  • 70
    • 0028082271 scopus 로고
    • Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group
    • Cohen M, Adams PC, Parry G, Xiong J, Chamberlain D, Wieczorek I, Fox KA, Chesebro JH, Strain J, Keller C. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group. Circulation. 1994;89:81-88.
    • (1994) Circulation , vol.89 , pp. 81-88
    • Cohen, M.1    Adams, P.C.2    Parry, G.3    Xiong, J.4    Chamberlain, D.5    Wieczorek, I.6    Fox, K.A.7    Chesebro, J.H.8    Strain, J.9    Keller, C.10
  • 77
    • 0033851515 scopus 로고    scopus 로고
    • Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction
    • Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959-969.
    • (2000) J Am Coll Cardiol , vol.36 , pp. 959-969
    • Alpert, J.S.1    Thygesen, K.2    Antman, E.3    Bassand, J.P.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.